NCT05838716 | URCC-22053 | URCC
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
NCT05946213 | NRG-GU013 | NRG
The Phase III `High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer
NCT06470243 | S2312 | SWOG
A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate Resistant Prostate Cancer (MCRPC), Stratified by Aggressive Variant Signature
NCT06931340 | A032302 | ALLIANCE
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)